Events & Presentations
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
October 21st to 23rd, Berlin
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
June 5th, 2026 - Royal Sonesta New Orleans
David Spencer, PhD - Chief Scientific Officer, Phoenix SENOLYTIX, Inc.
May 11-15th, Boston
Presenter: Kevin Slawin, M.D., Founder and CEO, Phoenix SENOLYTIX
September 16 - 19, 2025, Rome, Italy
Keshav Karki PhD, Daniel L. Jasinski PhD, Kevin M Slawin MD, and David M Spencer PhD
May 13th, 2025 | New Orleans, LA
Improved ApoptiCIDe™ Safety Switch Provides a Novel, Controllable Therapeutic Platform for Regulated Klotho Anti-Aging Gene Therapy
© 2026 Phoenix SENOLYTIX.